88P Real-world data of patients (pts) with BRAF V600E-mutated (mt) metastatic colorectal cancer (mCRC) treated with trifluridine/tipiracil (FTD–TPI)
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.05.099
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
3
Citations
1
h-index
0
i10-index
Pablo Gómez Mugarza is an academic researcher from Hospital Universitario Miguel Servet. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Neuroendocrine Tumor Research Advances & Colorectal and Anal Carcinomas. The author has an h-index of 1, co-authored 8 publications.
ORCID: 0009-0006-6856-7013Click to start Chat